“INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”. 2024. Journal of Population Therapeutics and Clinical Pharmacology 31 (9): 1502-18. https://doi.org/10.53555/68zhqm37.